Receiving a “poor responder” label during IVF is one of the most emotionally devastating moments in a fertility journey. You’ve prepared, you’ve hoped, and then you learn your ovaries didn’t produce the eggs your clinic was expecting. The grief is real, the confusion is real, and the desperate search for answers that follows is completely understandable. You are not alone in wondering whether there is something — anything — you can do differently before the next cycle.
Poor ovarian response is typically defined by low antral follicle counts, elevated FSH, diminished AMH, or fewer than four eggs retrieved during stimulation. These markers often reflect reduced ovarian reserve, mitochondrial dysfunction within aging or compromised eggs, or chronic oxidative stress that impairs follicular development. For some women, age is the primary driver. For others, previous chemotherapy, surgical history, endometriosis, or autoimmune conditions play a role. Understanding the root cause matters because it shapes which supplementation strategies may actually help.
In this article, we walk through the clinical evidence behind the most researched poor responder IVF supplements — including CoQ10, DHEA, melatonin, and vitamin D. We also cover practical timing strategies, lifestyle factors that amplify supplement benefits, and the questions most women have about safety and dosing. Our goal is to give you honest, evidence-grounded information so you can have a more informed conversation with your reproductive endocrinologist.
CoQ10 and DHEA: The Two Most Studied Supplements for Poor Responders
Coenzyme Q10 (CoQ10) is arguably the most researched supplement for poor ovarian response. Its primary role is in mitochondrial energy production — the very process that powers follicular development and egg maturation. As women age or experience oxidative stress, cellular CoQ10 levels decline, which may impair oocyte quality. A 2018 randomized controlled trial published in the Journal of Clinical Medicine found that CoQ10 supplementation before IVF was associated with higher fertilization rates and better embryo quality in women with diminished ovarian reserve. Doses used in research typically range from 400 mg to 600 mg daily, taken for at least 60 days before retrieval to allow mitochondrial saturation.
DHEA (dehydroepiandrosterone) has been studied extensively in the context of diminished ovarian reserve. It is a precursor to both estrogen and testosterone, and adequate intraovarian androgen levels appear to support follicular recruitment and granulosa cell function. Multiple observational studies and some randomized trials suggest that DHEA supplementation at 25–75 mg daily for 6–12 weeks before IVF can improve antral follicle counts, AMH levels, and egg yield in poor responders. You can read more about this mechanism in our dedicated article on DHEA supplementation for diminished ovarian reserve.
Key practical points for using these supplements:
- Start CoQ10 at least 60–90 days before your planned retrieval — mitochondrial support takes time to build at the cellular level.
- Choose ubiquinol over ubiquinone for CoQ10 if you are over 35, as ubiquinol is the active, more bioavailable form.
- DHEA should only be used under physician supervision — excess androgens can disrupt cycle regularity and affect embryo implantation.
- Combine CoQ10 with antioxidants such as vitamin E and vitamin C to extend its protective effect within follicular fluid.
- Consistency matters more than dose escalation — steady daily intake at evidence-based doses outperforms sporadic high-dose supplementation.
For women researching high-quality CoQ10 options, our guide to the best CoQ10 supplements for fertility provides a detailed breakdown of what to look for on the label.
Melatonin, Vitamin D, and Antioxidant Support for Egg Quality
Melatonin is increasingly recognised as more than just a sleep hormone. Within the ovary, melatonin is found at high concentrations in follicular fluid, where it acts as a potent antioxidant protecting maturing oocytes from reactive oxygen species. A 2017 study published in the Journal of Ovarian Research demonstrated that melatonin supplementation (3 mg nightly) in IVF patients significantly improved fertilization rates and reduced markers of oxidative stress in follicular fluid. For poor responders in particular, this antioxidant protection may help preserve the quality of the limited eggs retrieved.
Vitamin D deficiency is surprisingly common among infertile women and has been associated with reduced ovarian reserve, lower AMH, and poorer IVF outcomes across multiple studies. A 2019 meta-analysis in Reproductive BioMedicine Online found that women with sufficient vitamin D levels had significantly higher clinical pregnancy rates following IVF compared to deficient women. Because vitamin D receptors are present in granulosa cells and the endometrium, optimising levels (ideally above 40 ng/mL) may support both egg development and implantation. Our article on low AMH and natural supplement support explores this connection in more detail.
Additional antioxidant supplements with emerging evidence include:
- N-acetyl cysteine (NAC) — a glutathione precursor that reduces follicular oxidative damage and may improve ovarian response in women with PCOS or endometriosis.
- Alpha-lipoic acid — a mitochondria-supportive antioxidant that works synergistically with CoQ10 to protect oocyte DNA integrity.
- Vitamin E — shown in small trials to improve endometrial thickness and reduce oxidative stress markers in women undergoing stimulation.
- Omega-3 fatty acids — associated with improved oocyte morphology and reduced systemic inflammation that can impair follicular recruitment.
- Myo-inositol — supports FSH signalling within granulosa cells and has improved oocyte maturity rates in several randomised trials involving poor responders.
Women managing PCOS alongside poor ovarian response may benefit from the evidence on NAC for PCOS and fertility that we cover elsewhere on this site.
How Timing and Nutrient Absorption Affect Outcomes
Even the most evidence-backed supplement will underperform if timing and absorption are not optimised. The human oocyte completes its final maturation over approximately 90 days — a window that mirrors the preantral-to-antral follicle development process. This is why most researchers and reproductive endocrinologists recommend beginning a targeted supplement protocol at least three months before a planned egg retrieval. Beginning a week before stimulation is unlikely to produce meaningful cellular changes in time.
Absorption varies considerably between supplement forms and individuals. Fat-soluble nutrients — including CoQ10, vitamin D, and vitamin E — should be taken with a meal containing dietary fat to maximise uptake. Water-soluble nutrients like myo-inositol and NAC are better tolerated on an empty stomach or between meals. Splitting daily doses where possible (for example, 200 mg of CoQ10 twice daily rather than 400 mg once) may also improve plasma concentrations throughout the day.
Gut health plays a surprisingly important role in nutrient bioavailability. Women with chronic gut issues, low stomach acid, or previous antibiotic use may absorb minerals and fat-soluble vitamins poorly even when taking adequate doses. Addressing gut health before and during a supplementation protocol — through dietary fibre, fermented foods, and possibly a targeted probiotic — can meaningfully improve the actual cellular delivery of fertility nutrients. Chronic inflammation also impairs nutrient utilisation, which is why an anti-inflammatory dietary foundation amplifies what supplements can achieve.
Medical interactions are another timing consideration. Some supplements interact with fertility medications: high-dose antioxidants have been debated in the context of stimulation cycles, and melatonin may affect the timing of hormone surges if taken incorrectly. Always disclose every supplement to your reproductive endocrinologist before your stimulation protocol begins, not after.
Building a Realistic Supplement Strategy With Your Clinic
The most effective supplement strategy for a poor responder is one that is individualised, supervised, and sustainable. No supplement replaces medical intervention, and the evidence base — while growing — is still more robust for some nutrients than others. Approaching your clinic with specific questions about CoQ10, DHEA, vitamin D, and melatonin shows that you are engaged and research-aware, and most reproductive endocrinologists will welcome the conversation.
Before purchasing a supplement stack, ask your clinic to run baseline bloodwork including vitamin D, ferritin, thyroid function (TSH and Free T4), and if possible, an antioxidant capacity panel. Deficiencies in these areas are common and correctable, and treating a true deficiency will almost always produce more benefit than adding a supplement on top of already-adequate levels. Our comprehensive guide to how to improve egg quality after 35 provides additional context on interpreting these results.
Practical steps for building your protocol with your medical team include prioritising the supplements with the strongest evidence (CoQ10 and DHEA if appropriate), obtaining a vitamin D test before supplementing, discussing melatonin with your doctor specifically around the stimulation cycle, and simplifying wherever possible to avoid supplement fatigue. Consistency over months matters far more than a complicated daily regimen that becomes impossible to maintain. Women preparing for IVF may also benefit from reviewing our article on how to prepare your body for pregnancy in 3 months for a broader preconception framework.
Finally, emotional wellbeing is not separate from physical preparation. Chronic psychological stress elevates cortisol and suppresses the HPO axis, directly impairing follicular development. Incorporating stress-reduction practices — whether meditation, gentle movement, acupuncture, or therapy — alongside a targeted supplement protocol creates the most supportive internal environment possible for your next cycle.
Frequently Asked Questions
How long should I take supplements before an IVF cycle as a poor responder?
Most evidence supports starting key supplements like CoQ10 and DHEA at least 60–90 days before your planned retrieval date. This three-month window aligns with the natural development timeline of the follicles that will be stimulated during your cycle, allowing meaningful cellular changes to occur.
Is DHEA safe to take without a doctor’s supervision?
DHEA is not recommended without medical oversight. Excess androgen exposure can disrupt cycle regularity, affect embryo implantation, and cause side effects including acne, hair changes, and mood shifts. Your reproductive endocrinologist should assess your baseline androgen levels before recommending a dose.
Can melatonin interfere with fertility medications during IVF stimulation?
Melatonin is generally considered safe at low doses (1–3 mg) during the pre-stimulation phase, but its use during active stimulation should be discussed with your clinic. Some protocols recommend discontinuing melatonin once stimulation injections begin to avoid any potential interference with hormonal timing.
Does vitamin D really make a difference for IVF outcomes?
Multiple meta-analyses have found associations between adequate vitamin D status and improved clinical pregnancy rates in IVF. Women with levels above 30–40 ng/mL tend to have better outcomes. Testing your level first is essential, as supplementing when already sufficient provides limited additional benefit.
Are there any supplements poor responders should avoid before IVF?
High-dose herbal supplements including vitex, ashwagandha, and certain adaptogens should be used cautiously and disclosed to your clinic, as they can influence FSH, LH, and estrogen levels. Avoid any supplement that has not been discussed with your reproductive endocrinologist before your stimulation protocol begins.
A Word From Vitamins For Woman
Navigating IVF as a poor responder requires courage, patience, and access to accurate information — and we hope this guide has provided a useful, honest starting point. The evidence for targeted poor responder IVF supplements continues to grow, but supplements work best as part of a broader strategy that includes medical supervision, nutritional foundations, and consistent self-care. Please always discuss any new supplement with your reproductive endocrinologist before beginning, and remember that your circumstances are unique. We are here to support your journey with evidence-based guidance every step of the way.
References
- Bentov Y et al. (2018). Coenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF-ICSI treatment. Clinical Medicine Insights: Reproductive Health. https://pubmed.ncbi.nlm.nih.gov/29367831/
- Xu Y et al. (2017). Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology. Journal of Ovarian Research. https://pubmed.ncbi.nlm.nih.gov/28610654/
- Barad D et al. (2007). Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. Reproductive BioMedicine Online. https://pubmed.ncbi.nlm.nih.gov/17562282/
- Chu J et al. (2019). The role of vitamin D in reproductive outcomes of women with IVF treatment: a systematic review and meta-analysis. Reproductive BioMedicine Online. https://pubmed.ncbi.nlm.nih.gov/30661978/
- Unfer V et al. (2016). Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocrine Connections. https://pubmed.ncbi.nlm.nih.gov/27352453/
